Cure MSA

Country specific patient information



Abstracts of the Serono Symposia International, 2nd International Meeting on Multiple System Atrophy. Rome, Italy, June 17-18, 2004. Funct Neurol 2004; 19: 135-51. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Abdo WF, De Jong D, Hendriks JC, Horstink MW, Kremer BP, Bloem BR, et al. Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease. Mov Disord 2004; 19: 571-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Abele M, Klockgether T, Wullner U. Spectral analysis of heart rate variability in multiple system atrophy and unexplained sporadic ataxia. J Neurol 2004; 251: 894-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Armstrong RA, Cairns NJ, Lantos PL. A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA). J Neural Transm 2004; 111: 485-95. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Armstrong RA, Lantos PL, Cairns NJ. Spatial patterns of alpha-synuclein positive glial cytoplasmic inclusions in multiple system atrophy. Mov Disord 2004; 19: 109-12. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Involvement of medullary serotonergic groups in multiple system atrophy. Ann Neurol 2004; 55: 418-22. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Chou KL, Forman MS, Trojanowski JQ, Hurtig HI, Baltuch GH. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. J Neurosurg 2004; 100: 553-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Chrysostome V, Tison F, Yekhlef F, Sourgen C, Baldi I, Dartigues JF. Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology 2004; 23: 201-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Cormican LJ, Higgins S, Davidson AC, Howard R, Williams AJ. Multiple system atrophy presenting as central sleep apnoea. Eur Respir J 2004; 24: 323-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Deguchi K, Sasaki I, Touge T, Tsukaguchi M, Takeuchi H, Kuriyama S. Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy. J Neurol Neurosurg Psychiatry 2004; 75: 110-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Eckert T, Eidelberg D. The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy. Clin Auton Res 2004; 14: 84-91. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, et al. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 2004; 21: 229-35. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Fernagut PO, Diguet E, Bioulac B, Tison F. MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. Exp Neurol 2004; 185: 47-62. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Garland EM, Vnencak-Jones CL, Biaggioni I, Davis TL, Montine TJ, Robertson D. Fragile X gene premutation in multiple system atrophy. J Neurol Sci 2004; 227: 115-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Goldstein DS. Case 27-2004: multiple-system atrophy. N Engl J Med 2004; 351: 2881-3; author reply 2881-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gurevich TY, Groozman GB, Giladi N, Drory VE, Hausdorff JM, Korczyn AD. R-R interval variation in Parkinson's disease and multiple system atrophy. Acta Neurol Scand 2004; 109: 276-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Hamaguchi H, Kanda F, Hosaka K, Fujii M, Chihara K. [Comparison between MRI and 3D-SSP in olivopontocerebellar atrophy and cortical cerebellar atrophy]. Rinsho Shinkeigaku 2004; 44: 263-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Iranzo A, Santamaria J, Tolosa E, Vilaseca I, Valldeoriola F, Marti MJ, et al. Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 2004; 63: 930-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, Hirose T. Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 2004; 63: 43-52. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Jain S, Dawson J, Quinn NP, Playford ED. Occupational therapy in multiple system atrophy: a pilot randomized controlled trial. Mov Disord 2004; 19: 1360-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kagohashi M, Okuma Y, Fujishima K, Kitada T, Mizuno Y. Blepharospasm associated with multiple system atrophy: a case report and review of the literature. Parkinsonism Relat Disord 2004; 10: 169-71. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kanazawa M, Shimohata T, Terajima K, Onodera O, Tanaka K, Tsuji S, et al. Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging. J Neurol 2004; 251: 1121-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Knudsen GM, Karlsborg M, Thomsen G, Krabbe K, Regeur L, Nygaard T, et al. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 2004; 31: 1631-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Lee EA, Cho HI, Kim SS, Lee WY. Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism Relat Disord 2004; 10: 363-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Lezcano E, Gomez-Esteban JC, Zarranz JJ, Alcaraz R, Atares B, Bilbao G, et al. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report. Mov Disord 2004; 19: 973-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Lin WL, DeLucia MW, Dickson DW. Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy. Neurosci Lett 2004; 354: 99-102. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Lu CS, Weng YH, Chen MC, Chen RS, Tzen KY, Wey SP, et al. 99mTc-TRODAT-1 imaging of multiple system atrophy. J Nucl Med 2004; 45: 49-55. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Martin RA. Case 27-2004: multiple-system atrophy. N Engl J Med 2004; 351: 2881-3; author reply 2881-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Meier DS, Weiner HL, Khoury SJ, Guttmann CR. Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy. J Neuroimaging 2004; 14: 46S-53S. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Moro-de-Casillas ML, Cohen ML, Riley DE. Leucoencephalopathy with neuroaxonal spheroids (LENAS) presenting as the cerebellar subtype of multiple system atrophy. J Neurol Neurosurg Psychiatry 2004; 75: 1070-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Neumann M, Muller V, Gorner K, Kretzschmar HA, Haass C, Kahle PJ. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathol 2004; 107: 489-96. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Nishie M, Mori F, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T, et al. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol 2004; 107: 292-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Nishie M, Mori F, Yoshimoto M, Takahashi H, Wakabayashi K. A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 2004; 30: 546-54. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127: 2657-71. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ozsancak C, Auzou P, Dujardin K, Quinn N, Destee A. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease. J Neurol 2004; 251: 1317-23. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Pearce JM. From orthostatic hypotension to Shy-Drager syndrome. J Neurol Neurosurg Psychiatry 2004; 75: 1666. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Pereira LC, Palter VN, Lang AE, Hutchison WD, Lozano AM, Dostrovsky JO. Neuronal activity in the globus pallidus of multiple system atrophy patients. Mov Disord 2004; 19: 1485-92. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Podnar S, Fowler CJ. Sphincter electromyography in diagnosis of multiple system atrophy: technical issues. Muscle Nerve 2004; 29: 151-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Pountney DL, Lowe R, Quilty M, Vickers JC, Voelcker NH, Gai WP. Annular alpha-synuclein species from purified multiple system atrophy inclusions. J Neurochem 2004; 90: 502-12. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Resibois A, Poncelet L. Olivopontocerebellar atrophy in two adult cats, sporadic cases or new genetic entity. Vet Pathol 2004; 41: 20-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Rogge N. [Progressive gait instability and weakness with recurrence presyncopes/syncopes. Multiple system atrophy]. Schweiz Rundsch Med Prax 2004; 93: 68-71. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakakibara R, Hiruma K, Arai K, Uchiyama T, Hattori T. Head-turning dizziness in multiple system atrophy. Parkinsonism Relat Disord 2004; 10: 255-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakakibara R, Odaka T, Uchiyama T, Liu R, Asahina M, Yamaguchi K, et al. Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy. Mov Disord 2004; 19: 924-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakakibara R, Uchida Y, Uchiyama T, Yamanishi T, Hattori T. Reduced cerebellar vermis activation during urinary storage and micturition in multiple system atrophy: 99mTc-labelled ECD SPECT study. Eur J Neurol 2004; 11: 705-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Santamaria J, Iranzo A, Tolosa E. [Sleep disorders in multiple system atrophy]. Neurologia 2004; 19: 307-11. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sasaki H. [Multiple system atrophy--update]. Rinsho Shinkeigaku 2004; 44: 979-81. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Schatz IJ. Case 27-2004: multiple-system atrophy. N Engl J Med 2004; 351: 2881-3; author reply 2881-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 2004; 21: 1443-51. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Seppi K, Schocke MF, Donnemiller E, Esterhammer R, Kremser C, Scherfler C, et al. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Mov Disord 2004; 19: 1438-45. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Stefanova N, Lundblad M, Tison F, Poewe W, Cenci MA, Wenning GK. Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy). Neurobiol Dis 2004; 15: 630-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

 

Stefanova N, Mitschnigg M, Ghorayeb I, Diguet E, Geser F, Tison F, et al. Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration. J Neurosci Res 2004; 78: 87-91. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tachibana N, Oka Y. Longitudinal change in REM sleep components in a patient with multiple system atrophy associated with REM sleep behavior disorder: paradoxical improvement of nocturnal behaviors in a progressive neurodegenerative disease. Sleep Med 2004; 5: 155-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 2004; 55: 125-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ukkonen M, Elovaara I, Dastidar P, Tammela TL. Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system. Acta Neurol Scand 2004; 109: 100-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 2004; 45: 933-42. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Verbeek MM, Abdo WF, De Jong D, Horstink MW, Kremer BP, Bloem BR. Cerebrospinal fluid Abeta42 levels in multiple system atrophy. Mov Disord 2004; 19: 238-40; author reply 240-1. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Vetrugno R, Provini F, Cortelli P, Plazzi G, Lotti EM, Pierangeli G, et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med 2004; 5: 21-30. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wali GM. Asymmetrical awake bruxism associated with multiple system atrophy. Mov Disord 2004; 19: 352-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Watanabe H, Fukatsu H, Hishikawa N, Hashizume Y, Sobue G. Field strengths and sequences influence putaminal MRI findings in multiple system atrophy. Neurology 2004; 62: 671. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Watanabe H, Fukatsu H, Katsuno M, Sugiura M, Hamada K, Okada Y, et al. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry 2004; 75: 103-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Watanabe H, Takeda A, Kawai Y, Sobue G. [Cognitive impairment in patients with multiple system atrophy]. Nippon Rinsho 2004; 62 Suppl: 127-31. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol 2004; 3: 93-103. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 2004; 19: 1391-402. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wu YR, Chen CM, Ro LS, Lyu RK, Tang LM. Sensory neuropathy as the initial manifestation of multiple system atrophy. J Formos Med Assoc 2004; 103: 727-30. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wullner U, Abele M, Schmitz-Huebsch T, Wilhelm K, Benecke R, Deuschl G, et al. Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry 2004; 75: 924-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Yabe I, Soma H, Takei A, Fujik N, Sasaki H. No association between FMR1 premutations and multiple system atrophy. J Neurol 2004; 251: 1411-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Yazawa R, Kondo T, Miyashita T, Koide Y, Andoh T, Yamada Y. [Anesthetic management of a patient with olivopontocerebellar atrophy using heart rate variability (HRV)]. Masui 2004; 53: 55-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Young TM, Mathias CJ. The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry 2004; 75: 1737-41. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J Neuroimaging 2004; 14: 27S-35S. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Abele M, Riet A, Hummel T, Klockgether T, Wullner U. Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. J Neurol 2003; 250: 1453-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Antonini A, Benti R, De Notaris R, Tesei S, Zecchinelli A, Sacilotto G, et al. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci 2003; 24: 149-50. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Asahina M, Kikkawa Y, Suzuki A, Hattori T. Cutaneous sympathetic function in patients with multiple system atrophy. Clin Auton Res 2003; 13: 91-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Benarroch EE. Brainstem in multiple system atrophy: clinicopathological correlations. Cell Mol Neurobiol 2003; 23: 519-26. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy. Brain 2003; 126: 2183-90. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Benarroch EE, Schmeichel AM, Parisi JE. Preservation of branchimotor neurons of the nucleus ambiguus in multiple system atrophy. Neurology 2003; 60: 115-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Berding G, Brucke T, Odin P, Brooks DJ, Kolbe H, Gielow P, et al. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy. Nuklearmedizin 2003; 42: 31-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Berding G, Schrader CH, Peschel T, van den Hoff J, Kolbe H, Meyer GJ, et al. [N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 2003; 30: 127-31. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Bosman T, Van Laere K, Santens P. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging 2003; 30: 16-24. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Braak H, Rub U, Del Tredici K. Involvement of precerebellar nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 2003; 29: 60-76. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Brenneis C, Seppi K, Schocke MF, Muller J, Luginger E, Bosch S, et al. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 2003; 18: 1132-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Cho S, Kim CH, Cubells JF, Zabetian CP, Hwang DY, Kim JW, et al. Variations in the dopamine beta-hydroxylase gene are not associated with the autonomic disorders, pure autonomic failure, or multiple system atrophy. Am J Med Genet A 2003; 120A: 234-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Combarros O, Infante J, Llorca J, Berciano J. Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy. Mov Disord 2003; 18: 1385-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Dujardin K, Defebvre L, Krystkowiak P, Degreef JF, Destee A. Executive function differences in multiple system atrophy and Parkinson's disease. Parkinsonism Relat Disord 2003; 9: 205-11. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gai WP, Pountney DL, Power JH, Li QX, Culvenor JG, McLean CA, et al. alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol 2003; 181: 68-78. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gerhard A, Banati RB, Goerres GB, Cagnin A, Myers R, Gunn RN, et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 2003; 61: 686-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Giasson BI, Mabon ME, Duda JE, Montine TJ, Robertson D, Hurtig HI, et al. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathol 2003; 106: 243-50. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gurevich T, Giladi N. Freezing of gait in multiple system atrophy (MSA). Parkinsonism Relat Disord 2003; 9: 169-74. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Hamzei F, Rijntjes M, Gbadamosi J, Fuchs K, Weiller C, Munchau A. Life-threatening respiratory failure due to cranial dystonia after dental procedure in a patient with multiple system atrophy. Mov Disord 2003; 18: 959-61. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Higo R, Tayama N, Watanabe T, Nitou T, Takeuchi S. Vocal fold motion impairment in patients with multiple system atrophy: evaluation of its relationship with swallowing function. J Neurol Neurosurg Psychiatry 2003; 74: 982-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Higo R, Tayama N, Watanabe T, Nitou T, Ugawa Y. Videofluoroscopic and manometric evaluation of swallowing function in patients with multiple system atrophy. Ann Otol Rhinol Laryngol 2003; 112: 630-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Hirayama M, Fukatsu H, Watanabe H, Koike Y, Noda A, Ito H, et al. Sequential constriction of upper airway and vocal cords in sleep apnoea of multiple system atrophy: low field magnetic resonance fluoroscopic study. J Neurol Neurosurg Psychiatry 2003; 74: 642-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Hishikawa N, Niwa J, Doyu M, Ito T, Ishigaki S, Hashizume Y, et al. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis. Am J Pathol 2003; 163: 609-19. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Holmberg B, Johnels B, Blennow K, Rosengren L. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy. Mov Disord 2003; 18: 186-90. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ichikawa Y, Takeda K, Murashima S, Sakuma H, Matsumura K, Hirano T, et al. Increased myocardial uptake of iodine-123 metaiodobenzylguanidine on delayed images, compared with early images, in patients with multiple system atrophy. Clin Nucl Med 2003; 28: 890-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ikeda K, Iwasaki Y, Kuwajima A, Iguchi H, Sunohara N, Nonaka I, et al. Preservation of branchimotor neurons of the nucleus ambiguus in multiple system atrophy. Neurology 2003; 61: 722-3; author reply 723. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kamitani T, Kuroiwa Y, Wang L, Li M, Ikegami T, Matsubara S. Event-related potentials during visual S1-S2 paradigm in multiple system atrophy: relation to morphologic changes on brain MRI measurement. Parkinsonism Relat Disord 2003; 10: 93-100. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kim HS, Lee MS. Frequencies of single nucleotide polymorphism in alcohol dehydrogenase7 gene in patients with multiple system atrophy and controls. Mov Disord 2003; 18: 1065-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res 2003; 15: 293-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kleiner-Fisman G, Fisman DN, Kahn FI, Sime E, Lozano AM, Lang AE. Motor cortical stimulation for parkinsonism in multiple system atrophy. Arch Neurol 2003; 60: 1554-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kofler M, Muller J, Seppi K, Wenning GK. Exaggerated auditory startle responses in multiple system atrophy: a comparative study of parkinson and cerebellar subtypes. Clin Neurophysiol 2003; 114: 541-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

Komori T, Ishizawa K, Arai N, Hirose T, Mizutani T, Oda M. Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathol 2003; 106: 66-70. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kovacs T, Papp MI, Cairns NJ, Khan MN, Lantos PL. Olfactory bulb in multiple system atrophy. Mov Disord 2003; 18: 938-42. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Lass P, Slawek J, Derejko M, Dubaniewicz M. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy]. Neurol Neurochir Pol 2003; 37 Suppl 5: 263-74. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Levin OS, Khutorskaia OE, Amosova NA, Smolentseva IG, Shtok VN. [Clinical and electromyographical analysis of peculiarities of parkinsonian syndrome in multiple system atrophy and Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova 2003; 103: 4-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Lipp A, Tank J, Stoffels M, Arnold G, Luft FC, Jordan J. Riluzole and blood pressure in multiple system atrophy. Clin Auton Res 2003; 13: 271-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Malinovsky JM, Cozian A, Rivault O. Spinal anesthesia for transurethral prostatectomy in a patient with multiple system atrophy. Can J Anaesth 2003; 50: 962-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Miake H, Mizusawa H. [Diagnosis and therapy for patients with multiple system atrophy]. Nippon Naika Gakkai Zasshi 2003; 92: 1479-84. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Miwa H, Kajimoto Y, Nakanishi I, Morita S, Komoto J, Kihira T, et al. T2-low signal intensity in the cortex in multiple system atrophy. J Neurol Sci 2003; 211: 85-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Mori F, Nishie M, Yoshimoto M, Takahashi H, Wakabayashi K. Reciprocal accumulation of beta-synuclein in alpha-synuclein lesions in multiple system atrophy. Neuroreport 2003; 14: 1783-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, Yoshimoto M, et al. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol 2003; 62: 812-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Muratori LM, Reilmann R, Gordon AM. Coordination of fingertip forces during precision grasping in multiple system atrophy. Neuropsychologia 2003; 41: 1498-508. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Nahm F, Freeman R. Sphincter electromyography and multiple system atrophy. Muscle Nerve 2003; 28: 18-26. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Nakanishi I, Hironishi M, Miwa H, Kondo T. [A patient with multiple system atrophy presenting prolonged levodopa-responsive parkinsonism and off-dystonia of the trunk]. No To Shinkei 2003; 55: 605-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Oertel WH, Wachter T, Quinn NP, Ulm G, Brandstadter D. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov Disord 2003; 18: 430-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Pellegrinetti A, Moscato G, Siciliano G, Bonuccelli U, Orlandi G, Maritato P, et al. Electrophysiological evaluation of genito-sphincteric dysfunction in multiple system atrophy. Int J Neurosci 2003; 113: 1353-69. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Reich SG. The cold hands sign in MSA. Multiple system atrophy. Neurology 2003; 60: 719. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Riley DE, Chelimsky TC. Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 2003; 74: 56-60. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res 2003; 13: 106-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakakibara R, Uchiyama T, Asahina M, Yoshiyama M, Yamanishi T, Hattori T. Amezinium metilsulfate, a sympathomimetic agent, may increase the risk of urinary retention in multiple system atrophy. Clin Auton Res 2003; 13: 51-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Schatz IJ. A remarkable patient--40 years with probable multiple system atrophy (MSA). Clin Auton Res 2003; 13: 221-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Schott JM, Simon JE, Fox NC, King AP, Khan MN, Cipolotti L, et al. Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. Mov Disord 2003; 18: 955-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Seppi K, Schocke MF, Esterhammer R, Kremser C, Brenneis C, Mueller J, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003; 60: 922-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Shibuya K, Uchihara T, Nakamura A, Ishiyama M, Yamaoka K, Yagishita S, et al. Reversible conformational change of tau2 epitope on exposure to detergent in glial cytoplasmic inclusions of multiple system atrophy. Acta Neuropathol 2003; 105: 508-14. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Singleton CD, Robertson D, Byrne DW, Joos KM. Effect of posture on blood and intraocular pressures in multiple system atrophy, pure autonomic failure, and baroreflex failure. Circulation 2003; 108: 2349-54. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Smiley-Oyen AL, Worringham CJ, Cross CL. Motor learning processes in a movement-scaling task in olivopontocerebellar atrophy and Parkinson's disease. Exp Brain Res 2003; 152: 453-65. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Specht K, Minnerop M, Abele M, Reul J, Wullner U, Klockgether T. In vivo voxel-based morphometry in multiple system atrophy of the cerebellar type. Arch Neurol 2003; 60: 1431-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Stefanova N, Puschban Z, Fernagut PO, Brouillet E, Tison F, Reindl M, et al. Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol 2003; 106: 157-66. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sundar U, Sharma A, Arekar MA, Vimal P, Yeolekar ME. Olivopontocerebellar atrophy presenting with stridor. J Assoc Physicians India 2003; 51: 813-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Talman WT. Glutamate and blood pressure in multiple system atrophy. Clin Auton Res 2003; 13: 239-41. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tarsy D, Apetauerova D, Ryan P, Norregaard T. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology 2003; 61: 247-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Visser-Vandewalle V, Temel Y, Colle H, van der Linden C. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy--parkinsonism. Report of four cases. J Neurosurg 2003; 98: 882-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wang SR, Young YH. Multiple system atrophy manifested as dizziness and imbalance: a report of two cases. Eur Arch Otorhinolaryngol 2003; 260: 404-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Geser F. Multiple system atrophy. Rev Neurol (Paris) 2003; 159: 3S31-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Geser F, Poewe W. The 'risus sardonicus' of multiple system atrophy. Mov Disord 2003; 18: 1211. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Geser F, Stampfer-Kountchev M, Tison F. Multiple system atrophy: an update. Mov Disord 2003; 18 Suppl 6: S34-42. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Yamaguchi M, Arai K, Asahina M, Hattori T. Laryngeal stridor in multiple system atrophy. Eur Neurol 2003; 49: 154-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Yomono H, Kurisaki H, Murayama S, Hebisawa A, Miyajima H, Takahashi Y. [An autopsy case of multiple system atrophy with a heteroallelic ceruloplasmin gene mutation]. Rinsho Shinkeigaku 2003; 43: 398-402. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Benarroch EE. New findings on the neuropathology of multiple system atrophy. Auton Neurosci 2002; 96: 59-62. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Benarroch EE, Schmeichel AM, Parisi JE. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy. Neurology 2002; 59: 944-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Berciano J, Valldeoriola F, Ferrer I, Rumia J, Pascual J, Marin C, et al. Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study. Mov Disord 2002; 17: 812-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Berent S, Giordani B, Gilman S, Trask CL, Little RJ, Johanns JR, et al. Patterns of neuropsychological performance in multiple system atrophy compared to sporadic and hereditary olivopontocerebellar atrophy. Brain Cogn 2002; 50: 194-206. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Bhattacharya K, Saadia D, Eisenkraft B, Yahr M, Olanow W, Drayer B, et al. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol 2002; 59: 835-42. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Blumin JH, Berke GS. Bilateral vocal fold paresis and multiple system atrophy. Arch Otolaryngol Head Neck Surg 2002; 128: 1404-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Boesch SM, Wenning GK, Ransmayr G, Poewe W. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 72: 300-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Broussolle E, Verin M. [Contribution of MRI to the diagnosis of multiple system atrophy]. Rev Neurol (Paris) 2002; 158: 1243-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Chandler MP, Mathias CJ. Haemodynamic responses during head-up tilt and tilt reversal in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy. J Neurol 2002; 249: 542-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Colosimo C, Pezzella FR. The symptomatic treatment of multiple system atrophy. Eur J Neurol 2002; 9: 195-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Deguchi K, Sasaki I, Tsukaguchi M, Kamoda M, Touge T, Takeuchi H, et al. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci 2002; 199: 31-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Dirson G, Desjardins P, Tannenberg T, Dodd P, Butterworth RF. Selective loss of expression of glutamate GluR2/R3 receptor subunits in cerebellar tissue from a patient with olivopontocerebellar atrophy. Metab Brain Dis 2002; 17: 77-82. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002; 73: 517-23. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ghorayeb I, Fernagut PO, Hervier L, Labattu B, Bioulac B, Tison F. A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis. Neuroscience 2002; 115: 533-46. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ghorayeb I, Fernagut PO, Stefanova N, Wenning GK, Bioulac B, Tison F. Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys. Neurosci Lett 2002; 335: 34-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 72: 798-800. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gomez-Tortosa E, Gonzalo I, Newell K, Garcia Yebenes J, Vonsattel P, Hyman BT. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration. Acta Neuropathol 2002; 103: 495-500. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, et al. Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course? J Neurol 2002; 249: 847-54. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Isozaki E, Naito R, Kanda T, Mizutani T, Hirai S. Different mechanism of vocal cord paralysis between spinocerebellar ataxia (SCA 1 and SCA 3) and multiple system atrophy. J Neurol Sci 2002; 197: 37-43. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Jellinger KA. Neuropathological findings in multiple system atrophy with dystonia. J Neurol Neurosurg Psychiatry 2002; 73: 460-1. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kamitani T, Kuroiwa Y, Wang L, Li M, Suzuki Y, Takahashi T, et al. Visual event-related potential changes in two subtypes of multiple system atrophy, MSA-C and MSA-P. J Neurol 2002; 249: 975-82. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kawamoto Y, Akiguchi I, Nakamura S, Budka H. Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol 2002; 52: 722-31. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kikuchi A, Takeda A, Onodera H, Kimpara T, Hisanaga K, Sato N, et al. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis 2002; 9: 244-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Knopp DB, Barsottini OG, Ferraz HB. [Multiple system atrophy speech assessment: study of five cases]. Arq Neuropsiquiatr 2002; 60: 619-23. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Konagaya M, Konagaya Y, Sakai M, Matsuoka Y, Hashizume Y. Progressive cerebral atrophy in multiple system atrophy. J Neurol Sci 2002; 195: 123-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Konagaya M, Matsuoka Y, Konagaya Y. [Quantitative MRI study of progressive cerebral atrophy in multiple system atrophy]. Rinsho Shinkeigaku 2002; 42: 118-25. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kraft E, Trenkwalder C, Auer DP. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002; 59: 1265-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kumbier E, Kornhuber M. [Delusional ectoparasitic infestation in multiple system atrophy]. Nervenarzt 2002; 73: 380-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kurisaki H, Yomono H, Murayama S, Hebisawa A. [Multiple system atrophy with a-/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases]. Rinsho Shinkeigaku 2002; 42: 293-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Lee EA, Kim BJ, Lee WY. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography. Mov Disord 2002; 17: 1242-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Manto MU, Jacquy J, Legros B, Bosse P. Shift from hypermetria to hypometria in multiple system atrophy: analysis of distal and proximal movements. Neurol Res 2002; 24: 249-58. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Mathias CJ, Kimber J, Watson L, Muthane U. Is clonidine-growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease? J Neurol 2002; 249: 488-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Merlo IM, Occhini A, Pacchetti C, Alfonsi E. Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology 2002; 58: 649-52. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Mickey I, Kilford L, Kingsbury A, Loesch A. Endothelin in the middle cerebral artery: a case of multiple system atrophy. Histochem J 2002; 34: 469-77. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Moretti R, Torre P, Antonello RM, Carraro N, Zambito-Marsala S, Ukmar MJ, et al. Peculiar aspects of reading and writing performances in patients with olivopontocerebellar atrophy. Percept Mot Skills 2002; 94: 677-94. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Naka H, Imon Y, Ohshita T, Honjo K, Kitamura T, Miyachi T, et al. Magnetization transfer measurements of brain structures in patients with multiple system atrophy. Neuroimage 2002; 17: 1572-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Naka H, Ohshita T, Murata Y, Imon Y, Mimori Y, Nakamura S. Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes. Neuroradiology 2002; 44: 204-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Nishimura M, Kawakami H, Komure O, Maruyama H, Morino H, Izumi Y, et al. Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov Disord 2002; 17: 808-11. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K, et al. Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 73: 776-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002; 59: 1486-91. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ozawa T, Wakabayashi K, Oyanagi K. [Recent progress in the research of multiple system atrophy with special references to alpha-synuclein and suprachiasmatic nucleus]. No To Shinkei 2002; 54: 111-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Parikh SM, Diedrich A, Biaggioni I, Robertson D. The nature of the autonomic dysfunction in multiple system atrophy. J Neurol Sci 2002; 200: 1-10. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Pellecchia MT, Ambrosio G, Salvatore E, Vitale C, De Michele G, Barone P. Possible gluten sensitivity in multiple system atrophy. Neurology 2002; 59: 1114-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Righini A, Antonini A, Ferrarini M, de Notaris R, Canesi M, Triulzi F, et al. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J Comput Assist Tomogr 2002; 26: 266-71. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Riley DE. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 72: 286. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Rinne JO, Anichtchik OV, Eriksson KS, Kaslin J, Tuomisto L, Kalimo H, et al. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem 2002; 81: 954-60. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakurai A, Okamoto K, Yaguchi M, Fujita Y, Mizuno Y, Nakazato Y, et al. Pathology of the inferior olivary nucleus in patients with multiple system atrophy. Acta Neuropathol 2002; 103: 550-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Schocke MF, Seppi K, Esterhammer R, Kremser C, Jaschke W, Poewe W, et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002; 58: 575-80. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Strijks E, van't Hof M, Sweep F, Lenders JW, Oyen WJ, Horstink MW. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration. J Neurol 2002; 249: 1206-10. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sudo S, Fukutani Y, Matsubara R, Sasaki K, Shiozawa M, Wada Y, et al. Motor neuron disease with dementia combined with degeneration of striatonigral and pallidoluysian systems. Acta Neuropathol 2002; 103: 521-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Takanashi M, Ohta S, Matsuoka S, Mori H, Mizuno Y. Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological report of one case. Acta Neuropathol 2002; 103: 82-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Taniwaki T, Nakagawa M, Yamada T, Yoshida T, Ohyagi Y, Sasaki M, et al. Cerebral metabolic changes in early multiple system atrophy: a PET study. J Neurol Sci 2002; 200: 79-84. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Testa D, Tiranti V, Girotti F. Unusual association of sporadic olivopontocerebellar atrophy and motor neuron disease. Neurol Sci 2002; 23: 243-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tison F, Yekhlef F, Balestre E, Chrysostome V, Quinn N, Wenning GK, et al. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy. Mov Disord 2002; 17: 1248-54. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tison F, Yekhlef F, Chrysostome V, Balestre E, Quinn NP, Poewe W, et al. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease. Mov Disord 2002; 17: 701-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tsuda T, Onodera H, Okabe S, Kikuchi Y, Itoyama Y. Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy. Ann Neurol 2002; 52: 367-71. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Vallejo R, DeSouza G, Lee J. Shy-Drager syndrome and severe unexplained intraoperative hypotension responsive to vasopressin. Anesth Analg 2002; 95: 50-2, table of contents. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Valls-Sole J, Veciana M, Leon L, Valldeoriola F. Effects of a startle on heart rate in patients with multiple system atrophy. Mov Disord 2002; 17: 546-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wang Y, Lu C, Ye Z. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy. Chin Med J (Engl) 2002; 115: 1491-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002; 125: 1070-83. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Seppi K, Tison F, Jellinger K. A novel grading scale for striatonigral degeneration (multiple system atrophy). J Neural Transm 2002; 109: 307-20. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Winkler AS, Landau S, Chaudhuri KR. Serum prolactin levels in Parkinson's disease and multiple system atrophy. Clin Auton Res 2002; 12: 393-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Winkler AS, Landau S, Watkins P, Chaudhuri KR. Observations on haematological and cardiovascular effects of erythropoietin treatment in multiple system atrophy with sympathetic failure. Clin Auton Res 2002; 12: 203-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Yokochi F. [Multiple system atrophy which had been treated as juvenile Parkinson's disease]. No To Shinkei 2002; 54: 267-75. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

International medical workshop covering progressive supranuclear palsy, Multiple System Atrophy and cortico basal degeneration. Mov Disord 2001; 16: 382-95. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Badescu RC, Lalonde R. Associations between a cerebellar motor dysfunction scale and movement initiation and completion in olivopontocerebellar atrophy. Rev Neurol (Paris) 2001; 157: 1410-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Benarroch EE, Schmeichel AM. Depletion of corticotrophin-releasing factor neurons in the pontine micturition area in multiple system atrophy. Ann Neurol 2001; 50: 640-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Benarroch EE, Schmeichel AM, Parisi JE. Depletion of cholinergic neurons of the medullary arcuate nucleus in multiple system atrophy. Auton Neurosci 2001; 87: 293-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Block SA, Bakshi R. FLAIR MRI of striatonigral degeneration. Neurology 2001; 56: 1200. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Burk K, Skalej M, Dichgans J. Pontine MRI hyperintensities ("the cross sign") are not pathognomonic for multiple system atrophy (MSA). Mov Disord 2001; 16: 535. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Burn DJ, Jaros E. Multiple system atrophy: cellular and molecular pathology. Mol Pathol 2001; 54: 419-26. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Campbell BC, McLean CA, Culvenor JG, Gai WP, Blumbergs PC, Jakala P, et al. The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease. J Neurochem 2001; 76: 87-96. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Chuang C, Kocen RS, Quinn NP, Daniel SE. Case with both multiple system atrophy and primary progressive multiple sclerosis with discussion of the difficulty in their differential diagnosis. Mov Disord 2001; 16: 355-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Colosimo C, Vanacore N, Bonifati V, Fabbrini G, Rum A, De Michele G, et al. Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. Acta Neurol Scand 2001; 103: 261-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Deguchi K, Takeuchi H, Sasaki I, Tsukaguchi M, Touge T, Nishioka M. Impaired novelty P3 potentials in multiple system atrophy--correlation with orthostatic hypotension. J Neurol Sci 2001; 190: 61-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Eichhorn TE, Oertel WH. Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov Disord 2001; 16: 1176-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Eissler M, Holocher R, Lindenstrauss M, Wild K, Braun B. [Autonomic dysfunction with nocturnal dyspnea (Gerhardt-syndrome) in a patient with multiple system atrophy]. Med Klin (Munich) 2001; 96: 626-31. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Fowler CJ. Urinary disorders in Parkinson's disease and multiple system atrophy. Funct Neurol 2001; 16: 277-82. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Fowler CJ. Videodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001; 71: 575. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Friess E, Kuempfel T, Winkelmann J, Schmid D, Uhr M, Rupprecht R, et al. Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy. Arch Neurol 2001; 58: 241-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ghorayeb I, Puschban Z, Fernagut PO, Scherfler C, Rouland R, Wenning GK, et al. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration. Exp Neurol 2001; 167: 133-47. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gilman S. Biochemical changes in multiple system atrophy detected with positron emission tomography. Parkinsonism Relat Disord 2001; 7: 253-256. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Goldstein DS. Cardiac sympathetic neuroimaging to distinguish multiple system atrophy from Parkinson disease. Clin Auton Res 2001; 11: 341-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Hashimoto H, Nishiyama T, Nagase Y, Nakajima H, Yajima C, Hanaoka K. [Anesthesia for emergency surgery in a patient with Shy-Drager syndrome]. Masui 2001; 50: 40-1. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Hogl B, Seppi K, Brandauer E, Wenning G, Poewe W. Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report. Mov Disord 2001; 16: 1177-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Honjyo Y, Kawamoto Y, Nakamura S, Nakano S, Akiguchi I. P39 immunoreactivity in glial cytoplasmic inclusions in brains with multiple system atrophy. Acta Neuropathol 2001; 101: 190-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001; 71: 371-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Inoue K, Hashimoto I, Nakamura S. High-frequency oscillations in human posterior tibial somatosensory evoked potentials are enhanced in patients with Parkinson's disease and multiple system atrophy. Neurosci Lett 2001; 297: 89-92. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Isono S, Shiba K, Yamaguchi M, Tanaka A, Hattori T, Konno A, et al. Pathogenesis of laryngeal narrowing in patients with multiple system atrophy. J Physiol 2001; 536: 237-49. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kitae S, Murata Y, Tachiki N, Okazaki M, Harada T, Nakamura S. Assessment of cardiovascular autonomic dysfunction in multiple system atrophy. Clin Auton Res 2001; 11: 39-44. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Konagaya M, Yasuma F, Kuru S. Multiple system atrophy with paradoxical respiration. Respiration 2001; 68: 527. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Lantos PL. Diagnostic criteria of multiple system atrophy. J Neurol Neurosurg Psychiatry 2001; 70: 709. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Macia F, Yekhlef F, Ballan G, Delmer O, Tison F. T2-hyperintense lateral rim and hypointense putamen are typical but not exclusive of multiple system atrophy. Arch Neurol 2001; 58: 1024-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Magnifico F, Pierangeli G, Barletta G, Candela C, Bonavina G, Contin M, et al. The cardiovascular effects of metoclopramide in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001; 11: 163-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Manto MU, Moore J. Valproic acid toxicity mimicking multiple system atrophy. Neurology 2001; 57: 162. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Mark MH. Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration. Neurol Clin 2001; 19: 607-27, vi. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001; 11: 235-42. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Morris HR, Schrag A, Nath U, Burn D, Quinn NP, Daniel S, et al. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy. Neurosci Lett 2001; 312: 118-20. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Nakamura S, Kawamoto Y, Kitajima K, Honjo Y, Matsuo A, Nakano S, et al. Immunohistochemical localization of phosphoinositide 3-kinase in brains with multiple system atrophy. Clin Neuropathol 2001; 20: 243-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Nomura H, Konno H, Takase S, Saito H. Decrease of substance P in the parabrachial nucleus of multiple system atrophy. Auton Neurosci 2001; 92: 86-91. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Okuma Y, Mizuno Y. Myoclonic tremor in patients with parkinsonian-type multiple system atrophy. Mov Disord 2001; 16: 378-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, Tsuji S. Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol 2001; 102: 188-90. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ozawa T, Soma Y, Yoshimura N, Fukuhara N, Tanaka M, Tsuji S. Reduced morning cortisol secretion in patients with multiple system atrophy. Clin Auton Res 2001; 11: 271-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Pellecchia MT, Salvatore E, Pivonello R, Faggiano A, Barone P, De Michele G, et al. Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. Neurol Sci 2001; 22: 79-80. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Piao YS, Hayashi S, Hasegawa M, Wakabayashi K, Yamada M, Yoshimoto M, et al. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration. Acta Neuropathol 2001; 101: 285-93. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Pierangeli G, Provini F, Maltoni P, Barletta G, Contin M, Lugaresi E, et al. Nocturnal body core temperature falls in Parkinson's disease but not in Multiple-System Atrophy. Mov Disord 2001; 16: 226-32. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Rehman HU. Multiple system atrophy. Postgrad Med J 2001; 77: 379-82. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Robertson D, Shannon JR, Jordan J, Davis TL, Diedrich A, Jacob G, et al. Multiple system atrophy: new developments in pathophysiology and therapy. Parkinsonism Relat Disord 2001; 7: 257-260. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Rodolico C, Toscano A, De Luca G, Mazzeo A, Di Leo R, Baldari S, et al. Peripheral neuropathy as the presenting feature of multiple system atrophy. Clin Auton Res 2001; 11: 119-21. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Saitoh S. [Olivopontocerebellar atrophy]. Ryoikibetsu Shokogun Shirizu 2001: 364-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakae N, Ohyagi Y. [Shy-Drager syndrome]. Nippon Rinsho 2001; 59 Suppl 8: 483-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001; 71: 600-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Su M, Yoshida Y, Hirata Y, Watahiki Y, Nagata K. Primary involvement of the motor area in association with the nigrostriatal pathway in multiple system atrophy: neuropathological and morphometric evaluations. Acta Neuropathol 2001; 101: 57-64. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Testa D, Monza D, Ferrarini M, Soliveri P, Girotti F, Filippini G. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci 2001; 22: 247-51. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Thobois S, Broussolle E, Toureille L, Vial C. Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy. Mov Disord 2001; 16: 764-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, et al. Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci 2001; 22: 97-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord 2001; 16: 1023-32. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Vodusek DB. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord 2001; 16: 600-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Vodusek DB. Sphincter EMG in possible multiple system atrophy: to do or not to do? J Neurol Neurosurg Psychiatry 2001; 71: 575-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Waldner R, Puschban Z, Scherfler C, Seppi K, Jellinger K, Poewe W, et al. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). Neuroscience 2001; 102: 581-92. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Braune S. Multiple system atrophy: pathophysiology and management. CNS Drugs 2001; 15: 839-52. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Diem A. Is peripheral neuropathy a feature of multiple system atrophy? Clin Auton Res 2001; 11: 63. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Seppi K. [Diagnosis and therapy of multiple system atrophy]. Schweiz Rundsch Med Prax 2001; 90: 1035-40. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Seppi K, Scherfler C, Stefanova N, Puschban Z. Multiple system atrophy. Semin Neurol 2001; 21: 33-40. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Winkler AS, Marsden J, Parton M, Watkins PJ, Chaudhuri KR. Erythropoietin deficiency and anaemia in multiple system atrophy. Mov Disord 2001; 16: 233-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Abele M, Schulz JB, Burk K, Topka H, Dichgans J, Klockgether T. Evoked potentials in multiple system atrophy (MSA). Acta Neurol Scand 2000; 101: 111-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Abele M, Schulz JB, Burk K, Topka H, Dichgans J, Klockgether T. Nerve conduction studies in multiple system atrophy. Eur Neurol 2000; 43: 221-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Asahina M, Yamaguchi M, Fukutake T, Hattori T. [Sleep apnea in multiple system atrophy]. Nippon Rinsho 2000; 58: 1722-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Asato R, Akiguchi I, Masunaga S, Hashimoto N. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. J Neural Transm 2000; 107: 1427-36. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Clarke CE, Lowry M. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. Eur J Neurol 2000; 7: 661-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Colosimo C, Inghilleri M, Chaudhuri KR. Parkinson's disease misdiagnosed as multiple system atrophy by sphincter electro-myography. J Neurol 2000; 247: 559-61. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

De Marinis M, Stocchi F, Gregori B, Accornero N. Sympathetic skin response and cardiovascular autonomic function tests in Parkinson's disease and multiple system atrophy with autonomic failure. Mov Disord 2000; 15: 1215-20. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Druschky A, Hilz MJ, Platsch G, Radespiel-Troger M, Druschky K, Kuwert T, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 2000; 175: 3-12. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, et al. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol 2000; 59: 830-41. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Ghorayeb I, Fernagut PO, Aubert I, Bezard E, Poewe W, Wenning GK, et al. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. Mov Disord 2000; 15: 531-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Giladi N, Simon ES, Korczyn AD, Groozman GB, Orlov Y, Shabtai H, et al. Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease. Muscle Nerve 2000; 23: 731-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gill CE, Khurana RK. Caregiver burden in Shy-Drager syndrome. J Nerv Ment Dis 2000; 188: 47-50. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gilman S, Little R, Johanns J, Heumann M, Kluin KJ, Junck L, et al. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology 2000; 55: 527-32. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Gonzalez AM, Berciano J, Figols J, Pazos A, Pascual J. Loss of dopamine uptake sites and dopamine D2 receptors in striatonigral degeneration. Brain Res 2000; 852: 228-32. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Goto K, Ueki A, Shimode H, Shinjo H, Miwa C, Morita Y. Depression in multiple system atrophy: a case report. Psychiatry Clin Neurosci 2000; 54: 507-11. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, et al. Cerebral atrophy in multiple system atrophy by MRI. J Neurol Sci 2000; 173: 109-12. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Iranzo A, Santamaria J, Tolosa E. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet 2000; 356: 1329-30. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Isozaki E, Matsubara S, Hayashida T, Oda M, Hirai S. Morphometric study of nucleus ambiguus in multiple system atrophy presenting with vocal cord abductor paralysis. Clin Neuropathol 2000; 19: 213-20. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Jaros E, Burn DJ. The pathogenesis of multiple system atrophy: past, present, and future. Mov Disord 2000; 15: 784-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Jellinger KA, Wenning GK. An early description of striatonigral degeneration. J Neurol 2000; 247: 309-12. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kato S, Shinozawa T, Takikawa M, Kato M, Hirano A, Awaya A, et al. Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains. Acta Neuropathol 2000; 100: 481-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kawamoto Y, Nakamura S, Matsuo A, Akiguchi I. Glial cell line-derived neurotrophic factor-like immunoreactivity in the cerebella of normal subjects and patients with multiple system atrophy. Acta Neuropathol 2000; 100: 131-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kim GM, Kim SE, Lee WY. Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: studied with [(123)I]beta-CIT and SPECT. Eur Neurol 2000; 43: 23-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kofler M, Wenning GK, Poewe W, Jellinger K, Maier H. Cortical and brain stem hyperexcitability in a pathologically confirmed case of multiple system atrophy. Mov Disord 2000; 15: 362-3. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Kuiper MA, Teerlink T, Visser JJ, Bergmans PL, Scheltens P, Wolters EC. L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. J Neural Transm 2000; 107: 183-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Leiguarda R, Merello M, Balej J, Starkstein S, Nogues M, Marsden CD. Disruption of spatial organization and interjoint coordination in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. Mov Disord 2000; 15: 627-40. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Libelius R, Johansson F. Quantitative electromyography of the external anal sphincter in Parkinson's disease and multiple system atrophy. Muscle Nerve 2000; 23: 1250-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Morris HR, Vaughan JR, Datta SR, Bandopadhyay R, Rohan De Silva HA, Schrag A, et al. Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology 2000; 55: 1918-20. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Nakamura S, Kawamoto Y, Nakano S, Akiguchi I. Expression of the endocytosis regulatory proteins Rab5 and Rabaptin-5 in glial cytoplasmic inclusions from brains with multiple system atrophy. Clin Neuropathol 2000; 19: 51-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Pirker W, Asenbaum S, Bencsits G, Prayer D, Gerschlager W, Deecke L, et al. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 2000; 15: 1158-67. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Probst-Cousin S, Kayser C, Heuss D, Neundorfer B. [30 years multiple system atrophy concept: retrospect and overview of multiple system atrophy]. Fortschr Neurol Psychiatr 2000; 68: 25-36. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, et al. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Neuroscience 2000; 95: 377-88. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Puschban Z, Waldner R, Seppi K, Stefanova N, Humpel C, Scherfler C, et al. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy). Exp Neurol 2000; 164: 166-75. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Riley DE. Orthostatic Hypotension in Multiple System Atrophy. Curr Treat Options Neurol 2000; 2: 225-230. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Roane DM, Rogers JD, Helew L, Zarate J. Electroconvulsive therapy for elderly patients with multiple system atrophy: a case series. Am J Geriatr Psychiatry 2000; 8: 171-4. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Robertson D. Multiple system atrophy: the crime and the suspect. J Neurol Sci 2000; 175: 1-2. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakakibara R, Hattori T, Uchiyama T, Kita K, Asahina M, Suzuki A, et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry 2000; 68: 65-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Sakakibara R, Hattori T, Uchiyama T, Suenaga T, Takahashi H, Yamanishi T, et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 2000; 79: 191-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Salazar G, Valls-Sole J, Marti MJ, Chang H, Tolosa ES. Postural and action myoclonus in patients with parkinsonian type multiple system atrophy. Mov Disord 2000; 15: 77-83. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Scherfler C, Puschban Z, Ghorayeb I, Goebel GP, Tison F, Jellinger K, et al. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience 2000; 99: 43-54. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Schocke MF, Waldner R, Puschban Z, Kolbitsch C, Seppi K, Scherfler C, et al. In vivo magnetic resonance imaging of embryonic neural grafts in a rat model of striatonigral degeneration (multiple system atrophy). Neuroimage 2000; 12: 209-18. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Shibuya K, Nagatomo H, Iwabuchi K, Inoue M, Yagishita S, Itoh Y. Asymmetrical temporal lobe atrophy with massive neuronal inclusions in multiple system atrophy. J Neurol Sci 2000; 179: 50-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Shill HA, Fife TD. Valproic acid toxicity mimicking multiple system atrophy. Neurology 2000; 55: 1936-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Shoji M, Harigaya Y, Sasaki A, Ueda K, Ishiguro K, Matsubara E, et al. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2000; 68: 605-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Silber MH, Levine S. Stridor and death in multiple system atrophy. Mov Disord 2000; 15: 699-704. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Silveri MC, Misciagna S, Laudisio A, Colosimo C. Olivopontocerebellar atrophy: paraneoplastic syndrome of brain tumour? Eur J Neurol 2000; 7: 341-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Smith RL, Brown DH. Shy-Drager syndrome: an otolaryngology perspective. J Otolaryngol 2000; 29: 59-61. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Soliveri P, Monza D, Paridi D, Carella F, Genitrini S, Testa D, et al. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2000; 69: 313-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Spillantini MG, Goedert M. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 2000; 920: 16-27. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Stocchi F, Badiali D, Vacca L, D'Alba L, Bracci F, Ruggieri S, et al. Anorectal function in multiple system atrophy and Parkinson's disease. Mov Disord 2000; 15: 71-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Takatsu H, Nagashima K, Murase M, Fujiwara H, Nishida H, Matsuo H, et al. Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. Jama 2000; 284: 44-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Taniwaki T, Minohara M, Hara H, Ohyagi Y, Yamada T, Kira JI. Striatonigral degeneration with motor neuron disease. J Neurol 2000; 247: 395-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tison F. [Changes in clinical diagnostic criteria for multiple system atrophy]. Rev Neurol (Paris) 2000; 156: 711-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tison F, Arne P, Sourgen C, Chrysostome V, Yeklef F. The value of external anal sphincter electromyography for the diagnosis of multiple system atrophy. Mov Disord 2000; 15: 1148-57. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tison F, Yekhlef F, Chrysostome V, Sourgen C. Prevalence of multiple system atrophy. Lancet 2000; 355: 495-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease? J Neurol 2000; 247: 853-6. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Tsuchiya K, Ozawa E, Haga C, Watabiki S, Ikeda M, Sano M, et al. Constant involvement of the Betz cells and pyramidal tract in multiple system atrophy: a clinicopathological study of seven autopsy cases. Acta Neuropathol 2000; 99: 628-36. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Umeno H, Ueda Y, Mori K, Chijiwa K, Nakashima T, Kotby NM. Management of impaired vocal fold movement during sleep in a patient with Shy-Drager syndrome. Am J Otolaryngol 2000; 21: 344-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Vanacore N, Bonifati V, Fabbrini G, Colosimo C, Marconi R, Nicholl D, et al. Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology 2000; 54: 114-9. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Vogels OJ, Veltman J, Oyen WJ, Horstink MW. Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration. J Neurol Sci 2000; 180: 62-5. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wang L, Kuroiwa Y, Kamitani T, Li M, Takahashi T, Suzuki Y, et al. Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease. J Neurol 2000; 247: 356-63. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 68: 434-40. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Jellinger KJ, Quinn NP, Poewe WH. An early report of striatonigral degeneration. Mov Disord 2000; 15: 159-62. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wenning GK, Tison F, Scherfler C, Puschban Z, Waldner R, Granata R, et al. Towards neurotransplantation in multiple system atrophy: clinical rationale, pathophysiological basis, and preliminary experimental evidence. Cell Transplant 2000; 9: 279-88. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wetter TC, Collado-Seidel V, Pollmacher T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000; 23: 361-7. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Wullner U, Weller M, Kornhuber J, Bornemann A, Schulz JB, Riederer P, et al. Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cells. Mov Disord 2000; 15: 269-75. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Yamashita T, Ando Y, Obayashi K, Terazaki H, Sakashita N, Uchida K, et al. Oxidative injury is present in Purkinje cells in patients with olivopontocerebellar atrophy. J Neurol Sci 2000; 175: 107-10. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Yoshita M. Cardiac uptake of [123I]MIBG separates PD from multiple system atrophy. Neurology 2000; 54: 1877-8. www.ncbi.nlm.nih.gov/entrez/query.fcgi

 

 

Zuscik MJ, Sands S, Ross SA, Waugh DJ, Gaivin RJ, Morilak D, et al. Overexpression of the alpha1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat Med 2000; 6: 1388-94. www.ncbi.nlm.nih.gov/entrez/query.fcgi